AbbVie is nearing its 52-week high, driven by strong sales of SKYRIZI, its psoriasis and Crohn's disease treatment. However, potential risks to its stock price arise from market competition, pricing negotiations, and patent expirations. The company reported nearly $17 billion in…
On September 17, 2026, Aakash K Hindocha from Nuvama Wealth recommends Aegis Logistics, Aarti Pharmalabs, and Just Dial as top stocks to buy. Each stock has specific targets and s…
Broadcom has reported a remarkable 221% year-over-year growth in AI semiconductor revenue, yet its stock price has fallen significantly. Analysts suggest that the current stock pr…
OpenAI's recent court statements have shifted the timeline for its anticipated consumer device, providing Apple investors with a moment of relief. The company's lawyers indicated…
AMD has made significant strides in the tech sector, securing major commitments from companies like OpenAI, Meta, and Anthropic. With a year-to-date stock increase of 128.8% and a…
Palantir Technologies has reported significant earnings growth, with revenue increasing by 92.8% year-over-year in Q2 2026. Despite this growth, the stock has not seen a correspon…
Asian shares experienced a mostly positive trend as investors looked forward to the Federal Reserve's upcoming decision on interest rates, with many expecting a hike. Despite loss…
On September 16, 2026, Ganesh Dongre from Anand Rathi Shares and Stock Brokers Limited recommends three stocks for investors: PN Gadgil Jewellers, Mankind Pharma, and BEML. Each s…
Alphabet's stock is poised for growth as Google Cloud accelerates, showing an 82% increase in Q2. Despite this, the stock trades at a lower valuation compared to competitors, pres…
Amazon's stock has not seen sell ratings from analysts, yet it remains 12% below its 52-week high. With significant capital expenditures and a strong growth trajectory in AWS, the…
Disney's stock has not seen significant movement over the past year, trading at $107.24, which is 20% below Wall Street's average price target of $128.34. Despite reporting strong…
Meta Platforms has garnered attention from Wall Street analysts, with 55 Buy ratings and no Sell ratings, indicating strong confidence in the company's future. The current price t…
Goldman Sachs has identified a significant shift in the momentum of AI stocks, indicating that these stocks have moved to the short side of momentum trades. The bank's analysis re…
Nvidia's perpetual futures fell approximately 9% in a two-hour period, reflecting investor anxiety over reports that CEO Jensen Huang is being targeted by foreign intelligence. De…
U.S. refiner stocks have surged this year, significantly outperforming major oil companies like ExxonMobil and Chevron. As geopolitical tensions in the Middle East and Russia disr…
A recent trial failure by Novartis has adversely affected the entire Lp(a) drug class, with Amgen experiencing a significant drop in stock value despite its own positive trial res…